
Evotec A. G.
Use attributes for filter ! | |
Stock price | EVT |
---|---|
Disclaimer | |
Headquarters | Hamburg |
Germany | |
Ceo | Werner Lanthaler |
Revenue | 258 million EUR (2017) |
Subsidiaries | Aptuit LLC |
Just Biotherapeutics, Inc. | |
Cyprotex | |
Date of Reg. | |
Date of Upd. | |
ID | 1063125 |
About Evotec A. G.
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists.